Source: CURATED ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs10094872
rs10094872
CASC11
T 0.700 GeneticVariation GWASCAT This analysis, in combination with a two-staged replication in an additional 6,076 case and 7,555 control subjects from the PANcreatic Disease ReseArch (PANDoRA) and Pancreatic Cancer Case-Control (PanC4) Consortia uncovered 3 new pancreatic cancer risk signals marked by single nucleotide polymorphisms (SNPs) rs2816938 at chromosome 1q32.1 (per allele odds ratio (OR) = 1.20, P = 4.88x10 -15), rs10094872 at 8q24.21 (OR = 1.15, P = 3.22x10 -9) and rs35226131 at 5p15.33 (OR = 0.71, P = 1.70x10 -8). 27579533

2016
dbSNP: rs10094872
rs10094872
CASC11
T 0.700 GeneticVariation GWASCAT Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. 29422604

2018
dbSNP: rs104894360
rs104894360
KRAS
A 0.700 CausalMutation CLINVAR

dbSNP: rs10500715
rs10500715
SBF2
T 0.700 GeneticVariation GWASCAT Genome-wide association study of survival in patients with pancreatic adenocarcinoma. 23180869

2014
dbSNP: rs10835188
rs10835188
LIN7C
0.700 GeneticVariation GWASCAT Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study. 28470677

2017
dbSNP: rs10919791
rs10919791 		0.700 GeneticVariation GWASCAT Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. 25086665

2014
dbSNP: rs10983614
rs10983614
ASTN2
0.700 GeneticVariation GWASCAT Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study. 28470677

2017
dbSNP: rs11141915
rs11141915
DAPK1
T 0.800 GeneticVariation GWASDB A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy. 22293537

2012
dbSNP: rs11141915
rs11141915
DAPK1
T 0.800 GeneticVariation GWASCAT A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy. 22293537

2012
dbSNP: rs1131691003
rs1131691003
TP53
A 0.700 CausalMutation CLINVAR

dbSNP: rs1131691042
rs1131691042
TP53
T 0.700 CausalMutation CLINVAR

dbSNP: rs11540652
rs11540652
TP53
T 0.700 CausalMutation CLINVAR

dbSNP: rs11655237
rs11655237
LINC00511 ; LINC00673
T 0.720 GeneticVariation GWASCAT Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 26098869

2015
dbSNP: rs1169296
rs1169296
HNF1A
G 0.700 GeneticVariation GWASCAT Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. 30541042

2019
dbSNP: rs1182933
rs1182933
C12orf43
T 0.700 GeneticVariation GWASCAT Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. 29422604

2018
dbSNP: rs121912576
rs121912576
SMAD4
T 0.700 CausalMutation CLINVAR

dbSNP: rs121912577
rs121912577
SMAD4
G 0.700 CausalMutation CLINVAR

dbSNP: rs121912578
rs121912578
SMAD4
C 0.800 CausalMutation CLINVAR

dbSNP: rs121912578
rs121912578
SMAD4
0.800 GeneticVariation UNIPROT

dbSNP: rs121912579
rs121912579
SMAD4
T 0.700 CausalMutation CLINVAR

dbSNP: rs121912661
rs121912661
TP53
A 0.700 CausalMutation CLINVAR

dbSNP: rs121913529
rs121913529
KRAS
A 0.740 CausalMutation CLINVAR

dbSNP: rs121913529
rs121913529
KRAS
T 0.740 CausalMutation CLINVAR

dbSNP: rs12362504
rs12362504
SBF2 ; LOC101928008
C 0.700 GeneticVariation GWASCAT Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study. 28470677

2017
dbSNP: rs12413624
rs12413624 		T 0.700 GeneticVariation GWASCAT Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. 22158540

2011